2015 PCF Young Investigator Awards request for applications due June 3

The Prostate Cancer Foundation (PCF) is pleased to announce a request for applications for Young Investigator Awards.

PCF ( champions human capital investment to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from prostate cancer. The PCF Young Investigators Award program is one of our most significant efforts toward developing gifted cohorts of young prostate cancer researchers.

PCF Young Investigator Awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. Every PCF Young Investigator is required to be under the direct supervision of a mentor. Applicants should be within six-years following completion of a professional degree or clinical training such as MD, PhD, DSc, MD-PhD or equivalent and hold the title of Senior Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent. Applicants should have received no more than $200,000 in current direct research funding from all sources including institutional funds. Investigators who have specifically received young investigator research support from the NCI, NIH, or DoD are still qualified and very much encouraged to apply. Young Investigator awardees are required to attend the Annual PCF Scientific Retreat and Young Investigator Day, typically held in October, throughout the duration of their award.

Applications are encouraged from early-career basic scientists, medical oncologists, pathologists, urologists, radiologists, radiation oncologists, public health experts, bioinformaticians, bioengineers, or professionals from any other field that could contribute to the end of prostate cancer. Applicants may be working in basic, translational, or clinical research and need not be trained specifically in prostate cancer research. However, successful applicants should be working in a research environment capable of supporting transformational prostate cancer research. Access to and interaction with a clinical environment, as well as translational prostate cancer physician-scientists, is highly desirable.

View and Download RFA.


The online application submission portal will go live at on Friday, April 17, 2015. The deadline for application submission is Wednesday, June 3, 2015, 3:00 pm EDT. Please direct questions to